The discovery of these new actions of urotensin II can open a new avenue of research on the cardiovascular and endocrine effects of this peptide in forms of hypertension, as high-renin primary hypertension, renovascular hypertension, and renin-producing tumors, and chronic kidney disease patients where renin is inappropriately high for prevailing BP and salt intake. This evidence concerns the gene REN and Hypertension.